Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
National Institutes of Health Clinical Center (CC)
Regeneron Pharmaceuticals
St. Jude Children's Research Hospital
The Affiliated People's Hospital of Ningbo University
Memorial Sloan Kettering Cancer Center
New York Medical College
University of Miami
National Institutes of Health Clinical Center (CC)
New York Medical College
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
AIDS Malignancy Consortium
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Weill Medical College of Cornell University
Stanford University
Roswell Park Cancer Institute
City of Hope Medical Center
Universität des Saarlandes
Weill Medical College of Cornell University
SWOG Cancer Research Network
Columbia University
Masonic Cancer Center, University of Minnesota
CTI BioPharma
Fred Hutchinson Cancer Center
Celgene
University of Maryland, Baltimore
University of Maryland, Baltimore
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Seagen Inc.
St. Jude Children's Research Hospital
The First Affiliated Hospital with Nanjing Medical University
Soonchunhyang University Hospital
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Montefiore Medical Center
The University of Hong Kong
Asan Medical Center
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Stanford University